The MT3 WT + CFA group displayed an increase in arthritis scores compared with those in the non-CFA control group, whereas the MT3 KO + CFA group showed a substantial increase in arthritis scores relative to those in the MT3 WT + CFA group (Fig. 2C). This evidence concerns the gene MT3 and arthritic joint disease.